Patients who inhaled heparin were half as likely to require ventilation

Thursday, October 16th, 2025

Heparin, a widely available and affordable treatment for blood clots, has been shown to be effective in treating serious COVID-19 cases, according to a new international study led by researchers at the Australian National University (ANU) in collaboration with King’s College London:

The study analyzed data from almost 500 patients hospitalized with COVID-19 across six countries. Patients who inhaled heparin were half as likely to require ventilation and had a significantly lower risk of dying compared with those receiving standard care.

Heparin, a drug traditionally injected to treat blood clots, was tested in this study in an inhaled form, targeting the lungs directly. As well as acting as an anticoagulant, heparin has anti-inflammatory and pan-antiviral properties. Earlier research results showed breathing and oxygen levels improved in COVID-19 patients after they inhaled a course of heparin.

The researchers believe the drug could also be useful in fighting other serious respiratory infections such as pneumonia.

Comments

  1. Phileas Frogg says:

    The “Standard Care” from that time period was very revelatory concerning the capacity (both professional and moral) of the individuals in our medical system, and the ability of that system to promote or curtail the diffusion of potentially successful treatments and ideas.

    I find it astonishing that anyone in any Western country can look at what happened and come to any conclusion other than that it was, at minimum, a massive money laundering scheme.

  2. Jim says:

    I find it astonishing that anyone can look at what happened during the Rona and come to any conclusion other than that there is one world power and the visible states are but its puppets.

Leave a Reply